The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index; none of the 167 sources its claims cite is checked for support yet.
IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes‐related foot infections (IWGDF/IDSA 2023)
Open accessAbstract
The International Working Group on the Diabetic Foot (IWGDF) has published evidence‐based guidelines on the management and prevention of diabetes‐related foot diseases since 1999. The present guideline is an update of the 2019 IWGDF guideline on the diagnosis and management of foot infections in persons with diabetes mellitus. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework was used for the development of this guideline. This was structured around identifying clinically relevant questions in the P(A)ICO format, determining patient‐important outcomes, systematically reviewing the evidence, assessing the certainty of the evidence, and finally moving from evidence to the recommendation. This guideline was developed for healthcare professionals involved in diabetes‐related foot care to inform clinical care around patient‐important outcomes. Two systematic reviews from 2019 were updated to inform this guideline, and a total of 149 studies (62 new) meeting inclusion criteria were identified from the updated search and incorporated in this guideline. Updated recommendations are derived from these systematic reviews, and best practice statements made where evidence was not available. Evidence was weighed in light of benefits and harms to arrive at a recommendation. The certainty of the evidence for some recommendations was modified in this update with a more refined application of the GRADE framework centred around patient important outcomes. This is highlighted in the rationale section of this update. A note is also made where the newly identified evidence did not alter the strength or certainty of evidence for previous recommendations. The recommendations presented here continue to cover various aspects of diagnosing soft tissue and bone infections, including the classification scheme for diagnosing infection and its severity. Guidance on how to collect microbiological samples, and how to process them to identify causative pathogens, is also outlined. Finally, we present the approach to treating foot infections in persons with diabetes, including selecting appropriate empiric and definitive antimicrobial therapy for soft tissue and bone infections; when and how to approach surgical treatment; and which adjunctive treatments may or may not affect the infectious outcomes of diabetes‐related foot problems. We believe that following these recommendations will help healthcare professionals provide better care for persons with diabetes and foot infections, prevent the number of foot and limb amputations, and reduce the patient and healthcare burden of diabetes‐related foot disease.
Overview
CoChat Summary
TL;DR
This 2023 IWGDF/IDSA guideline updates recommendations for diagnosing and treating diabetes-related foot infections using GRADE, informed by updated systematic reviews that identified 149 studies (62 new). It emphasizes clinical diagnosis and severity classification, appropriate culture and imaging, pathogen-directed antibiotic therapy, and recommends against several adjunctive or topical treatments.
Key findings
- Diagnosis: diagnose soft-tissue infection clinically and assess severity with the IWGDF/IDSA classification (Strong; Low); consider tissue specimen culture rather than swab (Conditional; Moderate); use conventional rather than molecular microbiology first-line (Strong; Moderate); for osteomyelitis, consider probe-to-bone plus plain X-rays and ESR/CRP/PCT initially (Conditional; Low), MRI if doubt remains (Strong; Moderate), and bone rather than soft-tissue samples for culture (Conditional; Moderate).
- Treatment: for soft-tissue DFI, use any systemic regimen shown effective in RCTs at standard dosing (Strong; High) for 1–2 weeks (Strong; High), possibly up to 3–4 weeks if extensive and resolving slowly or with severe PAD (Conditional; Low); do not treat clinically uninfected ulcers with antibiotics to reduce infection risk or promote healing (Best Practice Statement).
- Osteomyelitis: consider up to 3 weeks of antibiotics after minor amputation with positive bone margin culture and 6 weeks without bone resection or amputation (Conditional; Low); consider surgical resection with systemic antibiotics (Conditional; Low) or antibiotics without surgery for selected forefoot osteomyelitis without immediate drainage need, PAD, or exposed bone (Conditional; Low).
- Adjunctive/topical: suggest not using G-CSF, topical antiseptics, silver preparations, honey, bacteriophage therapy, or negative-pressure wound therapy (Conditional; Low); not using topical antibiotics with systemic antibiotics (Conditional; Low); and not using HBO or topical oxygen therapy solely to treat a DFI (Conditional; Low).
Methods
- GRADE framework was used, structured around P(A)ICO questions, patient-important outcomes, systematic review of evidence, certainty assessment, and moving from evidence to recommendations; a multidisciplinary IWGDF/IDSA working group developed the guideline.
- Two 2019 systematic reviews were updated; 149 studies (62 new) meeting inclusion criteria were identified and incorporated; reviews followed PRISMA and protocols were registered in PROSPERO (CRD42022324795, CRD42022324812).
- Recommendations were discussed and voted on, with a 60% quorum required and majority vote for final decisions; strength was rated strong or conditional and certainty high, moderate, low, or very low.
Limitations
- The paper states many recommendations are conditional with low certainty, and evidence was limited by high risk of bias, inconsistency, imprecision, indirectness, and lack of a definitive criterion standard.
- The paper identifies areas with absent or inconsistent evidence, including rifampicin for diabetes-related foot osteomyelitis, bioactive glass, new antibiotics, molecular microbiology’s impact on management, optimal antibiotic durations, and whether bone biopsy improves outcomes.
- Evident from the text: this is a guideline based on systematic reviews and expert consensus rather than new primary data; the data availability statement says no new data were created or analyzed.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
0 Valid · 2 Not valid · 96 Not checked · 56 Own results and interpretations
In the paper
“However, there is no convincing data (from studies using either conventional culture or molecular methods) supporting this concept.72”
§ IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023) > Rationale
What the sources say
- Not matchedcites [72]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“While various imaging tests are widely used for diagnosing bone infection (see below), there are few data on their usefulness for softtissue infections.”
§ IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023) > Rationale
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Due to their limited specificity and sensitivity, not exceeding 0.85, when used as sole diagnostic tools, inflammatory biomarkers should be used when uncertainty persists after clinical assessment.”
§ IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023) > Rationale
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim could be matched to a paper in Crossref, so there is nothing to check it against.
In the paper
“Insufficient quality of evidence led us to not consider either laboratory risk indicators for necrotising fasciitis or SIRS as reliable tools for predicting lower extremity amputation, mortality, or other health outcomes.52,53”
§ IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023) > Rationale
What the sources say
- Not matchedcites [52]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [53]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, there are no data to support changing from using the systemic inflammatory response syndrome (SIRS) that is part of the IWGDF/IDSA classification to any other classification for DFIs.”
§ IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023) > Rationale
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
69 more claims
Create a free account to see all 154 claims and every source verdict.
- It may state two separate claims as one. 59
- Probably not a substantial claim. 27
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023) > Rationale
“Class 3/4: Moderate/severe Oral/initially iv 2-4 weeks”
§ IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023) > CONFLICT OF INTEREST STATEMENT
“Administer antibiotic therapy to a patient with a skin or soft tissue diabetic foot infection for a duration of 1-2 weeks.(Strong; High).”
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · cited 2×
“35,40 In addition, expert opinion, and aspects relevant to communicating to the reader regarding the intervention or recommendation can be added to these rationales.”
BackgroundPreferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Lipsky, B. A., Berendt, A. R., Cornia, P. B., Pile, J. C., Peters, E. J. G., Armstrong, D. G., Deery, H. G., Embil, J. M., Joseph, W. S., Karchmer, A. W., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis346 · Cited by 1,766
Self-citationDiagnosis and Treatment of Diabetic Foot Infections
Lipsky, B. A., Berendt, A. R., Deery, H. G., Embil, J. M., Joseph, W. S., Karchmer, A. W., LeFrock, J. L., Lew, D. P., Mader, J. T., Norden, C. W., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/424846 · Cited by 1,149
Self-citationSmith, G. B., Prytherch, D. R., Meredith, P., Schmidt, P. E., & Featherstone, P. I. (2013) · Resuscitation · doi:10.1016/j.resuscitation.2012.12.016 · Cited by 1,077
Prompers, L., Schaper, N., Apelqvist, J., Edmonds, M., Jude, E., Mauricio, D., Uccioli, L., Urbancic, V., Bakker, K., Holstein, P., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-0940-0 · Cited by 1,019
Lipsky, B. A., Senneville, É., Abbas, Z. G., Aragón‐Sánchez, J., Diggle, M. A., Embil, J. M., Kono, S., Lavery, L. A., Malone, M., van Asten, S. A. V., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3280 · Cited by 864
Self-citationAlonso-Coello, P., Oxman, A. D., Moberg, J., Brignardello-Petersen, R., Akl, E. A., Davoli, M., Treweek, S., Mustafa, R. A., Vandvik, P. O., Meerpohl, J., et al. (2016) · BMJ · doi:10.1136/bmj.i2089 · Cited by 814 · cited 1×
“35,40 In addition, expert opinion, and aspects relevant to communicating to the reader regarding the intervention or recommendation can be added to these rationales.”
Background
Research works printed but not linked: 7
- International Diabetes Federation, 2021, IDF Diabetes Atlas
- Malone M, 2022, A Systematic review of diagnosis of infection of the diabetic foot (soft tissue and bone): update, PROSPERO
- Malone M, 2022, A Systematic review of Interventions for diabetic foot infections (soft tissue and bone): update, PROSPERO
- Royal College of Physicians, 2012, National Early Warning Score (NEWS). Standardising the Assessment of Acute‐Illness Severity in the NHS
- Peters EJG, 2023, Diagnosis of infection in the foot of patients with diabetes: update 2023 systematic review, Diab Metab Res Rev
- 2017, Pexiganan versus placebo control for the treatment of mild infections of diabetic foot ulcers (OneStep‐2), Clinicaltrialsgov
- 2017, Pexiganan versus placebo control for the treatment of mild infections of diabetic foot ulcers (OneStep‐1), Clinicaltrialsgov
Cited by
Items 201–300 of 500
Ferramentas de avaliação de infecção em feridas agudas e crônicas: revisão de escopo
Lima, D. C. J., & Paes, G. O. (2025) · Revista da Escola de Enfermagem da USP · doi:10.1590/1980-220x-reeusp-2024-0392pt · Cited by 1
Tsapatsaris, A., Levy, D. A., Myers, A. K., Daily, J. P., & Kanneganti, M. (2025) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-25-0036 · Cited by 1
Bone Biopsy Microbiology Does Not Explain Clinical Severity in Diabetic Foot Osteomyelitis
Aragón‐Sánchez, J., Víquez‐Molina, G., & Rojas‐Bonilla, J. M. (2025) · The International Journal of Lower Extremity Wounds · doi:10.1177/15347346251353684 · Cited by 1
Self-citationMaurer, S. M., Maurer, M., Schmid, M., Dossi, S., Gautier, L., Boyd, A. E., Farshad, M., & Uçkay, İ. (2025) · Journal of Bone and Joint Infection · doi:10.5194/jbji-10-285-2025 · Cited by 1
Self-citationMetagenomic Insights into Therapeutic Strategies for Chronic Diabetic Wounds: A Review
Wong, Y. X., Saw, S. H., Lim, V., Lai, O. M., & Tan, C. X. (2025) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-025-00683-3 · Cited by 1
Diagnostic Value of Neutrophil CD64 Index in Diabetic Foot Osteomyelitis
Sun, H., Heng, H., Liu, X., Geng, H., & Liang, J. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s525260 · Cited by 1
Liu, L., Tao, Y., Zhang, D., Hou, J., Zhou, G., & Tian, M. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1660465 · Cited by 1
Nel, H., Stopher, L., Hanna, J., Manning, L. A., Jansen, S. J., & Gliddon, T. (2025) · The Journal of Foot & Ankle Surgery · doi:10.1053/j.jfas.2025.08.014 · Cited by 1
Guo, X., He, J., Jiang, X., Liu, F., Lei, B., Pan, H., Xiao, K., & Huang, R. (2025) · The International Journal of Lower Extremity Wounds · doi:10.1177/15347346251383638 · Cited by 1
LIMB PRESERVATION WITH CELLULAR, ACELLULAR AND MATRIX-LIKE PRODUCTS (CAMPS)
Cole, W., Abdo, R., Chatman, B. C., Couch, A. L., Davis, D., Lullove, E. J., Methodius-Rayford, W., Rogers, L. C., Snyder, R., Wu, S., et al. (2025) · Journal of Wound Care · doi:10.12968/jowc.2025.34.s11d.s1 · Cited by 1
Lin, W., You, M., Chen, Y., & Chen, J. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202503863 · Cited by 1
Özer, M. K. (2025) · Cureus · doi:10.7759/cureus.95492 · Cited by 1
Meddas, N., Gachet, B., Piraux, A., Senneville, E., Drudi, L. M., Brousseau‐Foley, M., & Blanchette, V. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.113035 · Cited by 1
Gonzalez, M. E., Burack, D. A., McCort, M., Thwe, P., Liriano-Ward, L., Goyal, R., & Bartash, R. (2025) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2025.10232 · Cited by 1
lian, F., Gu, J., Huan, J., Liu, Y., Lin, W., Lai, X., Zheng, X., Li, L., Li, W., Hou, X., et al. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02097-7 · Cited by 1
Jamil, E., Aziz, M. M., Altaf, U., Altowayan, W. M., Alqasoumi, A. A., Arooj, H., Almutairi, M. S., & Saleem, Z. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1752211 · Cited by 1
Metabolomics identifies chenodeoxycholic acid as a protective factor in diabetic foot ulcers
Li, Y., Guo, R., Lv, L., Jiang, T., Zhang, C., Chang, J., Hu, K., Peng, H., Chen, L., Chen, R., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1754743 · Cited by 1
Multani, A., Chowdhary, R., Schulman, Z., Reddy, M., Rosenzveig, A., Dixit, S., Multani, A., Wu, T., Dieter, R. S., & Nanjundappa, A. (2026) · International Journal of Angiology · doi:10.1055/a-2798-9516 · Cited by 1
Li, J., Shi, J., Gu, J., Cai, H., Gu, X., Yang, J., Tang, Z., & Wang, W. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1688571 · Cited by 1
Shin, C.-S., Kim, D.-W., Kim, J. L., & Kim, T.-H. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15052064 · Cited by 1
Larsen-Ramírez, A. F., & Nuzzolo-Shihadeh, L. (2026) · Clinical Infectious Diseases · doi:10.1093/cid/ciag167 · Cited by 1
dos Santos, C. F., dos Santos, V. P., Ferreira, L. D. M., Prado, N., Queiroz, A. B., Júnior, V. C., Caffaro, R. A., & Alves, C. A. S. (2026) · Jornal Vascular Brasileiro · doi:10.1590/1677-5449.202500971 · Cited by 1
Zuuri, C. N., Dotse, B. P., & Suglo, J. N. (2026) · BMC Nursing · doi:10.1186/s12912-026-04623-x · Cited by 1
Awad, G., Boutros, M., Abboud, E., Mjahed, G. A., & Yammine, K. (2026) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2026.03.008 · Cited by 1
Zhang, J., Jiang, X., Li, Y., & Lin, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1792343 · Cited by 1
Peng, X., Wang, W., Nie, X., & Hua, Q. (2026) · Scientific Reports · doi:10.1038/s41598-026-49753-z · Cited by 1
Lavery, L. A., Tarricone, A. N., Madsen, A. W. E., Thirugnanasambandam, N., Gee, A., Wukich, D. K., & Peters, E. J. G. (2026) · Wound Repair and Regeneration · doi:10.1111/wrr.70171 · Cited by 1
Self-citationChen, S., & Cui, X. (2026) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2026.5864 · Cited by 1
Ruano, R. D. L. C., Charles, M. T., Mengibar, J. L., Barbé, F., Ortiz-Zúñiga, Á., Hernández, M., Hernández, C., Simó, R., & Lecube, A. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1813327 · Cited by 1
Li, M., Zhu, C., Xu, Z., Feng, X., Zheng, G., & Li, Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1838948 · Cited by 1
Self-citationFeng, X., Yi, N., Zhang, C., Tang, L., Yin, X., Zhao, Y., Zhu, T., Zhu, J., Feng, Q., Chen, W., et al. (2026) · Chinese Medicine · doi:10.1186/s13020-026-01435-8 · Cited by 1
High Adherence to Remote Monitoring Technology in Patients at Risk for Diabetic Foot Ulcer
Yang, K., Rothenberg, G. M., Rincón, L., Fanas, R. L., Myers, A. K., Levy, D., & Daily, J. P. (2026) · International Wound Journal · doi:10.1111/iwj.70967 · Cited by 1
Performance, safety, and limitations of multimodal large language models in wound image assessment
Apichonbancha, S., Yodrabum, N., Tongsai, S., Thanapaisal, C., Sinmaroeng, C., & Winaikosol, K. (2026) · Scientific Reports · doi:10.1038/s41598-026-57441-1 · Cited by 1
Ghosh, A., Rastogi, A., Sahana, P. K., Agrawal, A. C., Mishra, A. K., Mohanty, D., Bodhey, N. K., Agarwala, P., Nanda, R., Bhattacharyya, M., et al. (2026) · JMIR Research Protocols · doi:10.2196/93492 · Cited by 1
Turner, K., Levy, D., Arce-Morales, J. L., Kanneganti, M., Daily, J. P., & Myers, A. K. (2026) · Diabetology · doi:10.3390/diabetology7070133 · Cited by 1
Wang, C., Zhang, Q., Wang, Y., Li, X., Yang, Y., Nie, S., Ge, S., Jiang, X., & ZHOU, J. (2026) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s620320 · Cited by 1
Yılmaz, K. B., Tulum, G., Cüce, F., Şimşek, Z., Mert, N. S., Horasan, S., Bozkurt, C., IŞIK, M. İ., Başak, A. M., & Osman, O. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1889329 · Cited by 1
Baligod, R. Q., Fabian, I. G. N., Repol, K. M., Sy, H. L., Marquez, J. C., & Agueda, J. R. H. S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156997 · Cited by 1
Bergqvist, K., Imberg, H., Hallström, S., Michelsen, J., Liljebäck, H., Franzén, S., Norhammar, A., Rosengren, A., & Lind, M. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03319-5 · Cited by 1
Shan, Q. (2026) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s643299 · Cited by 1
Eskandarnia, E., Binrajab, A., Alsaei, A., Rahimi, F., Alahmed, N., Zarwi, A., & Deen, G. R. (2026) · Journal of Functional Biomaterials · doi:10.3390/jfb17090444 · Cited by 1
Ramahi, J. W. A., Sharqawi, L., AL-Najafi, S., Awwad, E., Al-Obaidi, H. M., Mohammad, A. H., Nofal, S., Al-Janabi, D. R., Zuhair, I., Al-Masaeid, H. J., et al. (2024) · Advances in Infectious Diseases · doi:10.4236/aid.2024.142022 · Cited by 1
Aragón‐Sánchez, J., Víquez‐Molina, G., Aragón‐Hernández, J., & Rojas‐Bonilla, J. M. (2025) · The International Journal of Lower Extremity Wounds · doi:10.1177/15347346241312442 · Cited by 1
Self-citationClinical Decision-Making for Patients with Chronic Limb-Threatening Ischemia
Holder, T. A., & Gray, B. H. (2025) · Advances in Surgery · doi:10.1016/j.yasu.2025.04.002 · Cited by 1
Anders, C. B., Smith, H. L., Boyd, J. D., Davis, M. C., Lawton, T., Hwang, C., Doucette, M., & Ammons, M. C. B. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.07.674782 · Cited by 1
Marginal Bone in Diabetic Foot Osteomyelitis—An Important Part of a Bigger Puzzle
Motaganahalli, S., Karim, T., Vogrin, S., & Trubiano, J. A. (2026) · Clinical Infectious Diseases · doi:10.1093/cid/ciag570 · Cited by 1
Veve, M. P., & Patel, N. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae259
Knochen‑, Gelenk- und periprothetische Infektionen – eine interdisziplinäre Herausforderung
Jung, N. (2024) · rheuma plus · doi:10.1007/s12688-024-00777-1
Elnaim, A. L. K., & Mohamed, M. M. (2024) · Discover Medicine · doi:10.1007/s44337-024-00117-4
Tetanus development during hospitalization in an older adult
Okawa, N., & Hosokawa, N. (2024) · IDCases · doi:10.1016/j.idcr.2024.e02114
Topical esmolol hydrochloride as a novel treatment option for diabetic foot ulcers
Raley, D., Thornton, R., & Conway, S. (2024) · Evidence-Based Practice · doi:10.1097/ebp.0000000000002312
Громова, О. А., Torshin, I. Y., & Мойсеенок, А. Г. (2024) · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · doi:10.17749/2070-4909/farmakoekonomika.2024.285
Bone Voyage: Navigating Updates in the Management of Bone and Joint Infections
Santevecchi, B. A., Manigaba, K., & Childs‐Kean, L. M. (2025) · Current Infectious Disease Reports · doi:10.1007/s11908-024-00855-7
The value of slough in wounds for the diagnosis of microbiology cultivation
Li, Y., Cai, M., Li, N., Zhang, H., Huang, E., Zhao, J., JIN, M. L., & Zhang, L. (2025) · Wound Repair and Regeneration · doi:10.1111/wrr.70002
Varughese, J., Halfman, A., Crotty, M. P., Alexander, J., Hunter, L., Hupert, M., & Dominguez, E. A. (2025) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2025.24
Revaskularisation und Amputationsrisiko bei pAVK und Diabetes mellitus
Malyar, N. M., & Engelbertz, C. M. (2025) · Geriatrie up2date · doi:10.1055/a-2158-4083
Víquez‐Molina, G., Rojas‐Bonilla, J. M., & Aragón‐Sánchez, J. (2025) · The International Journal of Lower Extremity Wounds · doi:10.1177/15347346251323104
Self-citationLe pied diabétique : état des lieux, prévention et prise en charge
Galinat, S. (2025) · Actualités Pharmaceutiques · doi:10.1016/j.actpha.2024.12.022
Phua, S. Y., Cheong, C. Y. W., Chew, T., & Yong, E. (2025) · Journal of Wound Care · doi:10.12968/jowc.2025.34.sup4c.s22
Herramientas de evaluación de infecciones para heridas agudas y crónicas: una revisión del alcance
Lima, D. C. J., & Paes, G. O. (2025) · Revista da Escola de Enfermagem da USP · doi:10.1590/1980-220x-reeusp-2024-0392es
Sun, H., Zhang, S., Liu, X., Geng, H., & Liang, J. (2025) · The International Journal of Lower Extremity Wounds · doi:10.1177/15347346251340757
Betar, R., Verma, S. S., & Shrestha, P. (2025) · Case Reports in Clinical Medicine · doi:10.4236/crcm.2025.145034
Hu, J., Yu, Z., Deng, H., Chen, Y., & Jiang, Z. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-093342
Ahmed, S., Luu, V. T., Nsuga, T. C. O., Burgos, S. E., Kreys, E., Arquiette, J., & Lenhard, J. R. (2025) · Antibiotics · doi:10.3390/antibiotics14060597
Javanian, M., Khalilizad, M., Barary, M., Tayebi, P., & Ebrahimpour, S. (2025) · Wound Repair and Regeneration · doi:10.1111/wrr.70066
Dhawan, D., & Rosenblum, B. I. (2025) · Clinics in Podiatric Medicine and Surgery · doi:10.1016/j.cpm.2025.06.011
Danh, T. T., Trần, V. A., & Huỳnh, T. H. (2025) · Tạp chí Y Dược học Cần Thơ · doi:10.58490/ctump.2025i87.3739
TAN, J., Zhou, P. Y., Lim, J. L., Liu, F., & Kwa, L. H. A. (2025) · Antibiotics · doi:10.3390/antibiotics14080758
Antibiotic Therapy in the Diabetic Foot
Blackshear, L., Stead, W., & LaSalvia, M. T. (2025) · Clinics in Podiatric Medicine and Surgery · doi:10.1016/j.cpm.2025.06.013
Saade, R., & Choucair, J. (2025) · Research Square · doi:10.21203/rs.3.rs-7391175/v1
Gökçe, Ş., & Dolaş, Ö. (2025) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-025-01991-4
Luo, G., Zhang, T., Jiang, Y., Yuan, Q., Chen, P., & Hu, J. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1584976
Puttur, N., Manoj, R., Bhosale, K., Malik, N., Patil, P. S., Niezgoda, J., Madireddi, S., Gopalakrishnan, S., & Gupta, A. (2025) · Advances in Skin & Wound Care · doi:10.1097/asw.0000000000000349
Jiang, N., Zhang, X., Liu, Z., Wan, H., Huang, M.-Z., Lin, Q., Liu, G., Chen, P., & Yu, B. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1657099
Wound Bed Temperature as a Biomarker: Clinical Utility, Limitations and Future Directions
Xiao, D., & Zhao, Y. (2025) · Wound Repair and Regeneration · doi:10.1111/wrr.70097
Acral amelanotic melanoma mimicking common dermatologic conditions
Staroń, A. E., Wadowska, Z., Andriiash, V., Kiersznowska, N., Obtułowicz, A., Brzozowska, M., Obtułowicz, B., Dyduch, G., & Wojas‐Pelc, A. (2025) · Forum Dermatologicum · doi:10.5603/fd.106876
Parshutina, A. A., Parkhisenko, Y. A., Kovalev, S. A., & Bulynin, V. V. (2025) · Nauka molodykh (Eruditio Juvenium) · doi:10.23888/hmj2025133403-418
Clinical assessment of the risk of amputation in diabetic foot: A clinical case
Durdykulyyeva, M. (2025) · Bulletin Of Medical And Biological Research · doi:10.63341/bmbr/3.2025.54
Mahboob, A., Akram, M., Rauf, A., Saidmuratova, M., Djabbarov, I., Ali, S. K., Alamri, A. A., Asimov, A., Bahadur, A., Iqbal, S., et al. (2025) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-025-00631-0
Jan, A. U., & Ullah, I. (2025) · Healthcraft Frontiers · doi:10.56578/hf030202
Campbell, S. N., Mehaffey, M. R., Gambhir, N., & Killeen, A. L. (2025) · SAGE Open Medical Case Reports · doi:10.1177/2050313x251395970
Герасимчук, П. О., Фіра, Д. Б., & Pavlyshyn, A. V. (2025) · Науковий вісник Ужгородського університету Серія Медицина · doi:10.32782/2415-8127.2025.72.2
Panda, S. K., Mishra, P., Panigrahy, S., Pradhan, S., Parida, P. R., & Panda, M. (2025) · doi:10.51168/sjhrafrica.v6i12.2176
Surgical approaches to diabetic foot ulcers: an algorithm for applying the reconstructive ladder
Gupta, S. C., & Myint, J. A. (2025) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2025.93
Zhang, J., Li, X., Chang, B., Li, Y., & Chang, B. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1609128
Conduite à tenir devant un sepsis du pied chez une personne diabétique
Dupuy, O., Ahmed, S., & Masri, D. E. (2025) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2025.12.006
ANTIBIOTIC TREATMENT FAILURE OF STAPHYLOCOCCUS AUREUS IN DIABETIC SKIN AND SOFT TISSUE INFECTIONS
Shook, J. C. (2025) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/8hba-0269
Nguyen, V. D. (2023) · Papyrus : Institutional Repository (Université de Montréal) · doi:10.71781/4868
Revaskularisation und Amputationsrisiko bei pAVK und Diabetes mellitus
Malyar, N. M., & Engelbertz, C. (2025) · Diabetes aktuell · doi:10.1055/a-2716-2657
The effect of intensified lipid lowering therapy in diabetic patients with foot ulcers
Σιούτη-Δαδίνου, Ι. Χ., & Σιούτη-Δαδίνου, Ι. Χ. (2025) · University of Thessaly Institutional Repository (University of Thessaly)
Research Progress on Topical Treatments for Diabetic Foot Ulcers
刘, 启. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.15123605
Physical therapy in comprehensive treatment of peripheral artery disease and diabetes mellitus
Kasymova, A. R., Замалетдинов, Т. Р., Bikmetova, A. E., Sultanova, E. R., Bilalova, L. I., Sedakova, E. E., Shaikhutdinova, K. M., Abdulmedzhidova, Z. K., Antipina, A. S., Bidzhieva, A. A., et al. (2025) · Russian Journal of Physiotherapy Balneology and Rehabilitation · doi:10.17816/rjpbr688677
Gong, Y.-C., Wan, C.-C., Tang, P.-C., Xi, X., & Wang, G. (2025) · Evidence-Based Chinese Medicine and Technology Assessment · doi:10.26599/ecmta.2025.9570022
Small Artery Disease in Persons with Diabetic Foot Ulcers: Incidence, Characteristics, and Outcomes
Meloni, M., Morosetti, D., Uccioli, L., Bonanni, F. R., Salvi, M., Bellizzi, E., Argirò, R., Andreadi, A., Bellia, A., & Lauro, D. (2026) · The International Journal of Lower Extremity Wounds · doi:10.1177/15347346251411770
Bhandarkar, A. P., Kulkarni, S. S., Bhandarkar, A. P., & Matti, V. (2026) · Chronicle of Diabetes Research and Practice · doi:10.4103/cdrp.cdrp_20_25
Chen, G., LIU, H. B., Li, Q., Lu, L., Yang, X., Sun, Y., & Xu, Y. (2025) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm66473.2025.11356654
García, S. Z. (2025) · Repositori UJI (Universitat Jaume I)
Lower extremity outcomes in diabetic foot osteomyelitis: A systematic review and meta-analysis
Kaur, R., & Rastogi, A. (2026) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-026-01615-0
Doença do pé relacionada ao diabetes mellitus: atualização conceitual
Ferreira, J. R. D., de Castro, L. C., Moura, N. F. M., Rocha, R. M., Moraes, J. T., & Cortez, D. N. (2025) · Revista de Enfermagem do Centro-Oeste Mineiro · doi:10.19175/recom.v15i0.5505
Deng, L., li, X., Ran, J., Du, C., Chen, Y., Deng, W., Wang, M., & Yang, G. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02108-0
Metadata
- Authors
- Senneville, É., Albalawi, Z., van Asten, S. A., Abbas, Z. G., Allison, G., Aragón‐Sánchez, J., Embil, J. M., Lavery, L. A., Alhasan, M., Oz, O., Uçkay, I., Urbančič‐Rovan, V., Xu, Z., & Peters, E. J. G.
- Affiliations
- Université de Lille (FR)
- Memorial University of Newfoundland (CA)
- Leiden University (NL)
- Muhimbili University of Health and Allied Sciences (TZ)
- Tufts Medical Center (US)
- Hospital La Paloma (ES)
- University of Manitoba (CA)
- The University of Texas Southwestern Medical Center (US)
- Department of Medicine Prisma Health‐Midlands Columbia South Carolina USA
- UT Southwestern Medical Center Dallas Texas USA
- Balgrist University Hospital Zurich Switzerland
- University of Ljubljana (SI)
- Diabetes Centre Beijing China
- Amsterdam University Medical Centers (NL)
- Corresponding author
- Senneville, Éric
- ORCID
- Venue
- Diabetes/Metabolism Research and Reviews
- Publisher
- Wiley
- Published
- 2023-10
- Volume
- 40
- Issue
- 3
- Pages
- e3687-e3687
- ISSN
- 1520-7552 (ISSN-L)
- 1520-7560
- OpenAlex
- W4387241578
- Cited by
- 498
- References
- 172
- Citations by year
- 2026: 266 · 2025: 176 · 2024: 47 · 2023: 9
- FWCI
- 14.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes/Metabolism Research and Reviews (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
- Leiden Repository (Leiden University) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
- Health Sciences › Medicine › Surgery › Orthopedic Infections and Treatments
- Health Sciences › Medicine › Dermatology › Skin Diseases and Diabetes
- Keywords
- diabetic foot, soft tissue infection, bone infection, infection severity classification, microbiological sampling, antimicrobial therapy, empirical treatment, surgical treatment, adjunctive therapy, limb amputation prevention, foot care
- MeSH terms
- Communicable Diseases, Diabetes Mellitus, Foot, Humans, Diabetic Foot
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-13, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-13 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
